• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经母细胞瘤细胞死亡由无机三氧化二砷(As₂O₃)诱导,并受到一种源自正常人骨髓细胞的因子抑制。

Neuroblastoma cell death is induced by inorganic arsenic trioxide (As(2)O(3)) and inhibited by a normal human bone marrow cell-derived factor.

作者信息

Gesundheit Benjamin, Malach Lea, Or Reuven, Hahn Talia

机构信息

Department of Bone Marrow Transplantation, Hadassah University Hospital, Jerusalem, Israel.

出版信息

Cancer Microenviron. 2008 Dec;1(1):153-7. doi: 10.1007/s12307-008-0015-2. Epub 2008 Aug 27.

DOI:10.1007/s12307-008-0015-2
PMID:19308693
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2654357/
Abstract

Three phenotypically distinct cell types are present in human neuroblastomas (NB) and NB cell lines: I-type stem cells, N-type neuroblastic precursors, and S-type Schwannian/melanoblastic precursors. The stimulation of human N-type neuroblastoma cell proliferation by normal human bone marrow monocytic cell conditioned medium (BMCM) has been demonstrated in vitro, a finding consistent with the high frequency of bone marrow (BM) metastases in patients with advanced NB. Inorganic arsenic trioxide (As(2)O(3)), already clinically approved for the treatment of several hematological malignancies, is currently under investigation for NB. Recent studies show that As(2)O(3) induces apoptosis in NB cells. We examined the impact of BMCM on growth and survival of As(2)O(3)-treated NB cell lines, to evaluate the response of cultured NB cell variants to regulatory agents. We studied the effect of BMCM on survival and clonogenic growth of eleven As(2)O(3)-treated NB cell lines grown in sparsely seeded, non-adherent, semi-solid cultures. As(2)O(3) had a strong inhibitory effect on survival of all tested NB cell lines. BMCM augmented cell growth and survival and reversed the inhibitory action of As(2)O(3) in all tested cell lines, but most strongly in N-type cells(.) While As(2)O(3) effectively reduced survival of all tested NB cell lines, BMCM effectively impacted its inhibitory action. Better understanding of micro-environmental regulators affecting human NB tumor cell growth and survival may be seminal to the development of therapeutic strategies and clinically effective agents for this condition.

摘要

人类神经母细胞瘤(NB)和NB细胞系中存在三种表型不同的细胞类型:I型干细胞、N型成神经细胞前体和S型雪旺氏/成黑素细胞前体。正常人骨髓单核细胞条件培养基(BMCM)对人N型神经母细胞瘤细胞增殖的刺激作用已在体外得到证实,这一发现与晚期NB患者骨髓(BM)转移的高发生率一致。无机三氧化二砷(As(2)O(3))已被临床批准用于治疗几种血液系统恶性肿瘤,目前正在对NB进行研究。最近的研究表明,As(2)O(3)可诱导NB细胞凋亡。我们研究了BMCM对经As(2)O(3)处理的NB细胞系生长和存活的影响,以评估培养的NB细胞变体对调节因子的反应。我们研究了BMCM对在稀疏接种、非贴壁、半固体培养中生长的11种经As(2)O(3)处理的NB细胞系存活和克隆生长的影响。As(2)O(3)对所有测试的NB细胞系的存活均有强烈的抑制作用。BMCM促进了细胞生长和存活,并逆转了As(2)O(3)在所有测试细胞系中的抑制作用,但在N型细胞中作用最强。虽然As(2)O(3)有效地降低了所有测试NB细胞系的存活率,但BMCM有效地影响了其抑制作用。更好地了解影响人类NB肿瘤细胞生长和存活的微环境调节因子可能对开发针对这种疾病的治疗策略和临床有效药物至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aca/2654357/1f8a0ed74882/12307_2008_15_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aca/2654357/95373b294c07/12307_2008_15_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aca/2654357/1f8a0ed74882/12307_2008_15_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aca/2654357/95373b294c07/12307_2008_15_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2aca/2654357/1f8a0ed74882/12307_2008_15_Fig2_HTML.jpg

相似文献

1
Neuroblastoma cell death is induced by inorganic arsenic trioxide (As(2)O(3)) and inhibited by a normal human bone marrow cell-derived factor.神经母细胞瘤细胞死亡由无机三氧化二砷(As₂O₃)诱导,并受到一种源自正常人骨髓细胞的因子抑制。
Cancer Microenviron. 2008 Dec;1(1):153-7. doi: 10.1007/s12307-008-0015-2. Epub 2008 Aug 27.
2
Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.三氧化二砷在体内抑制神经母细胞瘤生长,在体外促进凋亡性细胞死亡。
Biochem Biophys Res Commun. 2000 Oct 14;277(1):179-85. doi: 10.1006/bbrc.2000.3651.
3
Human bone marrow-derived mitogenic stimulation selective for breast carcinoma and neuroblastoma cells.对乳腺癌和神经母细胞瘤细胞具有选择性的人骨髓源性促有丝分裂刺激因子。
Int J Cancer. 1998 Nov 23;78(5):624-8. doi: 10.1002/(sici)1097-0215(19981123)78:5<624::aid-ijc16>3.0.co;2-g.
4
Effects of stem cell factor and other bone marrow-derived growth factors on the expression of adhesion molecules and proliferation of human neuroblastoma cells.
Eur J Cancer. 1995;31A(4):467-70. doi: 10.1016/0959-8049(95)00049-o.
5
Control of neuroblastoma cell proliferation and differentiation by human bone marrow.人骨髓对神经母细胞瘤细胞增殖和分化的调控
Cancer. 1996 Jun 15;77(12):2614-21. doi: 10.1002/(SICI)1097-0142(19960615)77:12<2614::AID-CNCR27>3.0.CO;2-U.
6
The cellular response to PPARgamma ligands is related to the phenotype of neuroblastoma cell lines.
Oncol Res. 2004;14(7-8):345-54. doi: 10.3727/0965040041292297.
7
Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.在新建立的人类神经母细胞瘤模型中,核因子κB受体活化因子配体(RANKL)是破骨细胞形成导致骨转移的关键分子。
Cancer Res. 2001 Feb 15;61(4):1637-44.
8
Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.
Cancer Genet Cytogenet. 1999 Jul 15;112(2):124-9. doi: 10.1016/s0165-4608(98)00264-7.
9
Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.筛选一组具有不同作用机制的药物,可获得针对神经母细胞瘤的潜在治疗药物。
Cancer Biol Ther. 2009 Dec;8(24):2386-95. doi: 10.4161/cbt.8.24.10184. Epub 2009 Dec 27.
10
Requirement of soluble factors produced by bone marrow stromal cells on the growth of novel established human myeloma cell line.骨髓基质细胞产生的可溶性因子对新建立的人骨髓瘤细胞系生长的需求
Int J Oncol. 2003 Mar;22(3):631-7.

引用本文的文献

1
1,2-Benzenedithiol and Toluene-3,4-dithiol Arsenic(III) Complexes-Synthesis, Structure, Spectroscopic Characterization and Toxicological Studies.1,2-苯二硫醇和甲苯-3,4-二硫醇砷(III)配合物的合成、结构、光谱特性和毒理学研究。
Molecules. 2019 Oct 26;24(21):3865. doi: 10.3390/molecules24213865.
2
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.三氧化二砷作为131I-间碘苄胍治疗的辐射增敏剂:一项II期研究的结果
J Nucl Med. 2016 Feb;57(2):231-7. doi: 10.2967/jnumed.115.161752. Epub 2016 Jan 7.

本文引用的文献

1
Arsenic trioxide and neuroblastoma cytotoxicity.三氧化二砷与神经母细胞瘤细胞毒性
J Bioenerg Biomembr. 2007 Feb;39(1):35-41. doi: 10.1007/s10863-006-9058-6.
2
A patient with progressive multiple myeloma treated successfully with arsenic trioxide after allogeneic bone marrow transplantation.一名异基因骨髓移植后用三氧化二砷成功治疗的进行性多发性骨髓瘤患者。
Acta Haematol. 2007;117(2):119-21. doi: 10.1159/000097457. Epub 2006 Nov 29.
3
Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.
多药耐药神经母细胞瘤细胞在常氧和缺氧条件下均对三氧化二砷有反应。
Mol Cancer Ther. 2005 Jul;4(7):1128-35. doi: 10.1158/1535-7163.MCT-05-0047.
4
Arsenic trioxide: an anti cancer missile with multiple warheads.三氧化二砷:一枚带有多个弹头的抗癌导弹。
Hematology. 2005 Jun;10(3):205-13. doi: 10.1080/10245330500067090.
5
Characteristics of stem cells from human neuroblastoma cell lines and in tumors.源自人神经母细胞瘤细胞系及肿瘤的干细胞的特征
Neoplasia. 2004 Nov-Dec;6(6):838-45. doi: 10.1593/neo.04310.
6
Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.三氧化二砷诱导神经母细胞瘤细胞死亡涉及Bax激活且无需p53参与。
Clin Cancer Res. 2004 May 1;10(9):3179-88. doi: 10.1158/1078-0432.ccr-03-0309.
7
Bone marrow-derived factors support growth of N-type, but not of melanocytic neuroblastoma cells.骨髓衍生因子支持N型而非黑素细胞性神经母细胞瘤细胞的生长。
Anticancer Res. 2002 Nov-Dec;22(6C):4325-9.
8
Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.全面的基因和组织病理学研究揭示了三种类型的神经母细胞瘤肿瘤。
J Clin Oncol. 2001 Jun 15;19(12):3080-90. doi: 10.1200/JCO.2001.19.12.3080.
9
Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.三氧化二砷在体内抑制神经母细胞瘤生长,在体外促进凋亡性细胞死亡。
Biochem Biophys Res Commun. 2000 Oct 14;277(1):179-85. doi: 10.1006/bbrc.2000.3651.
10
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.采用强化化疗、放疗、自体骨髓移植及13-顺式维甲酸治疗高危神经母细胞瘤。儿童癌症研究组。
N Engl J Med. 1999 Oct 14;341(16):1165-73. doi: 10.1056/NEJM199910143411601.